Akso Health (AHG) Liabilities and Shareholders Equity (2017 - 2026)

Akso Health (AHG) has reported Liabilities and Shareholders Equity for 10 consecutive years, with $189.6 million the latest figure, recorded in Q1 2026.

• Quarterly Liabilities and Shareholders Equity fell 11.78% year-over-year to $189.6 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $829.6 million (up 41.37% YoY) and the FY2026 annual result came in at $189.6 million, down 11.78% from the prior year.
• Liabilities and Shareholders Equity declined to $189.6 million in Q1 2026 per AHG's latest filing, from $212.0 million in the prior quarter.
• Over the last five years, Liabilities and Shareholders Equity for AHG reached as high as $215.0 million in Q1 2025 and fell as low as $16.9 million in Q3 2023.
• A 5-year average of $121.4 million and a median of $142.0 million in 2024 frame the typical range for Liabilities and Shareholders Equity.
• Annual changes were most pronounced in 2022 — Liabilities and Shareholders Equity surged 64281681.64% — and 2023, when it sank 67.42%.
• Year by year, Liabilities and Shareholders Equity stood at $20.9 million in 2022, then slipped by 19.26% to $16.9 million in 2023, then jumped by 1161.51% to $212.9 million in 2024, then declined by 0.43% to $212.0 million in 2025, then fell by 10.57% to $189.6 million in 2026.
• According to Business Quant data, Liabilities and Shareholders Equity over the past three periods registered $189.6 million, $212.0 million, and $215.0 million for Q1 2026, Q3 2025, and Q1 2025 respectively.